您的购物车当前为空
KM02894 是一种谷氨酸释放抑制剂。癌细胞释放高水平的谷氨酸,能够破坏正常的骨转换,这可能导致癌症引起的骨痛。KM02894 可用于研究肿瘤相关疾病。

KM02894 是一种谷氨酸释放抑制剂。癌细胞释放高水平的谷氨酸,能够破坏正常的骨转换,这可能导致癌症引起的骨痛。KM02894 可用于研究肿瘤相关疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥ 111 | In Stock | |
| 25 mg | ¥ 177 | In Stock | |
| 50 mg | ¥ 283 | In Stock |
KM02894 相关产品
| 产品描述 | KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases. |
| 分子量 | 215.3 |
| 分子式 | C7H9N3OS2 |
| CAS No. | 116850-74-9 |
| Smiles | CNC(=S)NNC(=O)C1=CC=CS1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 30.0 mg/mL (139.3 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9.29 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容